Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Clinical trial NCT00225758 · TERMINATED
Trial details
- NCT number
- NCT00225758
- Sponsor
- Gary Schwartz
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2011-10-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.